Literature DB >> 25719981

Role of D-dimer Assays in the Diagnostic Evaluation of Pulmonary Embolism.

Snigdha Jain1, Rohan Khera, Manish Suneja, Brian Gehlbach, Ethan Kuperman.   

Abstract

The diagnosis of pulmonary embolism (PE) remains challenging despite the evolution of well-validated clinical algorithms over the past few decades, largely because of nonspecific clinical features altering clinician suspicion. D-dimer is a simple noninvasive test that is an essential part of the diagnostic algorithm but is often deemed to be of little value in patients who are elderly or have other comorbidities. We describe a case of an elderly man who presented with clinical features and initial imaging consistent with pneumonia and a positive D-dimer test. Adherence to the suggested diagnostic algorithm and obtaining chest imaging, however, prevented what could have been a catastrophic missed diagnosis of PE. We review existing evidence on the importance of suspecting PE in the presence of alternative diagnosis and explore the literature on the association between the magnitude of D-dimer and the diagnosis of PE.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25719981     DOI: 10.1097/MAJ.0000000000000405

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Clinical application of the Innovance D-dimer assay in the diagnosis of acute pulmonary thromboembolism.

Authors:  Zhuxiao Bai; Yurong Huang; Chenghua Song; Huimin Liu; Yihui Chen; Haitao Zhang; Xinhong Lu; Yingbo Song; Xin Zhang
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

2.  Predictive Value of Circulating microRNA-134 Levels for Early Diagnosis of Acute Pulmonary Embolism: Meta-analysis.

Authors:  Yu Liu; Ming Xie; Xiaoli Gao; Ran Liu
Journal:  J Cardiovasc Transl Res       Date:  2021-01-06       Impact factor: 4.132

3.  Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.

Authors:  Miao Wang; Qiguo Zhu; Jianguo Fu; Lilong Liu; Mingzhe Xiao; Yu Du
Journal:  Infect Genet Evol       Date:  2020-08-26       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.